Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patientsYann Vano, Réza Elaidi, Haïl Aboudagga et al.|PLoS ONE|2018Cited by 112
Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohortPauline Tétu, Célèste Lebbé, Julie De Quatrebarbes et al.|European Journal of Cancer|2019Cited by 35
Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanomaPauline Tétu, Célèste Lebbé, Bastien Oriano et al.|European Journal of Cancer|2018Cited by 14
FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated MelanomaPauline Tétu, Nicolas Dumaz|Cancers|2020Cited by 9